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Abstract 
Purpose: To determine genotypic distribution, ribonucleic acid (RNA) RNA viral load and express core 
gene from Hepatitis C Virus (HCV) infected patients in Punjab, Pakistan. 
 Methods: A total of 1690 HCV RNA positive patients were included in the study. HCV genotyping was 
tested by type-specific genotyping assay, viral load, by real time polymerase chain reaction (PCR) and 
HCV core protein was expressed in E. coli. Antigenicity of core protein was confirmed by enzyme-linked 
immunosorbant assay (ELISA). 
Results: Out of total 1690 serum samples, type-specific PCR fragments were observed in 1482 (87.69 
%) of the samples. In both genders, genotype 3a (55.44 %) was most prevalent followed by 3b (15.03 
%), 1a (6.98 %) and 1b (3.14 %). Regionally, genotype 3a occurred most frequently in Jaranwala (59.72 
%). Patients infected with genotype 3 had pre-treatment viral load values of 52.56, 15.79 and 31.65 %, 
while patients infected by other genotypes showed viral load values of 13.43, 35.27 and 51.3 % for low, 
intermediate and high categories of viral load, respectively. ELISA showed that core protein possessed 
greater antigenicity.  
Conclusion: HCV genotype 3a is the most prevalent genotype in Punjab, although the distribution of 
HCV genotypes in eight cities of Punjab was not uniform.  HCV core protein used to develop local 
screening assays may be more effective than current commercial assays. 
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The severity of HCV is well known all over the 
world. Prevalence of HCV is different in different 
geographical areas, which also depends on the 
different genotypes of HCV. These genotypes 
were developed from the high degree of HCV 
sequence variation. There are six major HCV 
genotype groups and seventy subgroups [1]. In 
certain geographic areas Genotypes 1, 2 and 3 
are more prevalent compared to 4, 5 and 6 which 
are present in other geographic areas.  
Genotypes 1 and 2 are predominantly present in 
the USA and Western Europe, genotype 4 found 
in Africa, genotype 5 in South Africa and 
genotype 3 in South East Asia, known genotypes 
do not have the same response to treatment 
strategies, so studying the geographic 
distribution of HCV genotypes is very helpful to 
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plan treatment strategies [2]. The other 
prognostic indicator is the pretreatment HCV viral 
load which is helpful in treatment decisions. High 
viral load was observed in some genotypes like 
genotype 1 as compared to other genotypes. 
Association of viral load and genotypes are not 
extensively studied but some association studies 
give the idea that high viral load is difficult to treat 
than low viral load [3]. HCV virion is enveloped 
positive strand RNA virus. It consists of 10 viral 
proteins which are divided into structural and 
nonstructural proteins. Core is a structural 
multifunctional protein and it affects host cell 
functions, including apoptosis, HCV associated-
steatosis, immune cell functions, cell 
transformation, signal transduction, and 
transcriptional regulation leading to Hepatitis Cell 
Carcinoma [4]. 
 
Prevalence of HCV in Pakistan is 4.8 % which is 
among the in the world countries [5]. Our study 
deals with the prevalence of HCV genotypes, 
viral load and expression of core gene in Punjab 
province of Pakistan. Punjab is the most 
populous province of Pakistan, with 
approximately 51.6% of the country's total 
population and 205344 total area in square 
kilometers [6]. This is the most developed, 
populous, and prosperous province in Pakistan. 
No study has been conducted in Punjab to 
evaluate the relationship between viral load and 
genotypes in HCV-infected patients. Since these 
two factors have significance in the treatment of 
patients, this study was conducted to determine 
genotypic distribution, RNA viral load and 
express core gene from HCV infected patients in 






Between the years 2007 and 2010, serum 
samples were collected from HCV-infected 
patients visiting collection centers/sub-centers of 
Citi Lab and Research Center, Lahore, Pakistan 
from eight different cities of Punjab, Pakistan. 
Data sheets with demographic characteristics, 
age, marital status and address from 
participating patients were filled by a research 
assistant. Patients were informed about the study 
and they gave their consent to participate in the 
study. The study was approved by the Ethics 
Committee of Citi Lab and Research Centre, 
Lahore, Pakistan (approval ref no. CLRC-143/11) 
and international guidelines for human studies 
were followed [7].  
 
 
HCV RNA quantitation 
 
RT-PCR of HCV RNA was performed using Mini 
OpticonTM System BIO-RAD Thermal Cycler. 
HCV RNA extraction and quantification Kits were 
manufactured by AJ Roboscreen  Germany. The 
kit shows a linear measurement between 6,000 
to 6,000,000,000 IU/ml and can detect < 172 
copies/ml HCV RNA. Specimens yielding values 
more than upper limit were diluted 100 times, 
tested again, then results obtained were 
multiplied to this dilution factor to get the actual 




HCV genotyping was performed with genotype 
specific primers based on PCR of Core region. 
cDNA was prepared with 50 ng of HCV RNA 
using 100 units of M-MuLV reverse transcriptase 
enzyme (Fermentas, Life Sciences, USA) at 37 
°C for 50 minutes. For first round PCR 
amplification 2µl cDNA was used. As we had to 
detect different genotypes so type specific 
primers were divided into two groups on the 
basis of sizes of different bands so no genotype 
specific primers were of the same size in the 
same group on agarose gel. Each first round 
PCR specimen was used to perform two second 
round nested PCR amplifications. One with mix-1 
primers and second with mix-2 primers in a 
reaction volume of 20µl. Mix-1 had genotype 
specific primers for 1b, 2a, 2b and 3b genotypes 
and Mix-2 had genotype specific primers for 
genotypes 1a, 3a, 4, 5a and 6a. Second round 
PCR products were observed on 2% agarose gel 
to separate type specific PCR fragment. DNA 
size marker 50bp DNA ladder (Fermentas, USA) 
was run on each gel. HCV genotype for each 
sample was determined by genotype specific 
PCR band. 
 
Cloning of core gene HCV in expression 
vector pET21a (+) 
 
pET21a (+) and core gene cDNA of HCV was 
digested thoroughly with Xbal and HindIII. The 
target gene and large fragment vector were 
purified by agarose gel electrophoresis. The 
573bp target gene fragment was ligated with 
5338bp linearized pET21a (+) plasmid vector by 
adding bacteriophage T4 DNA ligase overnight at 
22 °C and stored at -20 °C. The ligated product 
was transformed into E. coli, and was incubated 
in an LB agar plate containing ampicillin 
overnight at 37 °C. Eight bacterial colonies were 
individually transferred into 2 ml of LB medium 
containing ampicillin in a loosely capped 15 ml 
tube, and the culture was incubated overnight at 
37 °C with vigorous shaking. To confirm that the 
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culture did contain the correct plasmid; we 
prepared a small amount of plasmid DNA and 
analyzed it by digestion with restriction enzymes 
and was also sequenced.  
 
Identification of expressed proteins  
 
Twelve percent sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was used to identify the expressed 
proteins. The sample was prepared as follows: 1 
ml of induced culture was centrifuged to collect 
the pellet, and the pellet was re-suspended and 
boiled for 5 min to lyse the bacteria with 2×SDS 
loading buffer. After electrophoresis, the 
polyacrylamide gel was stained with Coomassie 
Brilliant Blue, and scanned to analyze the 
expression level of the recombinant protein. The 
recombinant protein was used as antigen to test 




Data were analyzed using SPSS, version 16. 
The results for all variables were given in the 
form of rates (%). Chi-Square or Fisher‘s exact 
test was applied to calculate p-value. P-values < 





The studied sample population comprised of 
1690 HCV infected patients. Out of which 1166 
(69 %) were males and 524 (31 %) were 
females. In both genders, genotype 3a (55.44 %) 
was most prevalent followed by 3b (15.03 %) and 
1a (6.98 %), in female patients genotype 3a was 
54% followed by 3b (18.51 %), 1a (4.96 %), 1b 
(4.39 %) and 2a (0.38 %) while in male patients 
genotype 3a was 56.08% followed by 3b (13.46 
%), 1a (7.89 %), 1b (2.57 %) and 2a (0.26 %). 
Mixed genotype percentage in female patients 
was 9.35 % while in males it was 5.66 %. 12.30 
% (n = 208) cases could not be genotyped. Data 
showed that HCV genotypes 1a, 3a and 3b (p-
value < 0.05) had statistically significant variation 
between both genders whereas genotypes 1b, 
2a and mixed (p > 0.05) genotypes were 
statistically insignificant (Table 1). 
 
Genotype distribution of HCV infected patients of 
different cities of the most populated province of 
Pakistan was evaluated (Table 2). Out of 617 
HCV isolates of Lahore most frequent genotype 
was 3a in 351 (56.82 %) patients followed by 3b 
with 90 (14.59 %) patients. 1a in Lahore was 
identified in 47 (7.62 %) patients followed by 1b 
in 17 (2.76 %). Only one isolate was identified of 
genotype 2a from Lahore. 46 (7.46 %) patients  
Table 1: Gender-wise genotype distribution in HCV-infected patients of Punjab (n = 1690) 
 
Genotype Male Female   Total Gender  
Subtype Frequency % Frequency % P-value Frequency % Ratio 
Genotype 1 122 10.46 49 9.35  171 10.12 2.49 
1a 92 7.89 26 4.96 0.000 118 6.98 3.54 
1b 30 2.57 23 4.39 0.336 53 3.14 1.3 
Genotype 2 3 0.26 2 0.38  5 0.3 1.5 
2a 3 0.26 2 0.38 0.665 5 0.3 1.5 
Genotype 3 811 69.6 380 72.52  1191 70.47 2.13 
3a 654 56.08 283 54 0.000 937 54.44 2.31 
3b 157 13.46 97 18.51 0.000 254 15.03 1.61 
Mixed Genotype 66 5.66 49 9.35 0.113 115 6.8 1.34 
Undetermined 164 14.06 44 8.4 0.000 208 12.3 3.73 
Total 1166 69 524 31   1690 100 2.22 
 
 
Table 2: Distribution of genotypes of HCV isolates from different cities of Punjab, Pakistan (n = 1690) 
 
   Genotype     City 
1a 1b 2a 3a 3b Mixed UN Total 
Lahore 47(7.62) 17(2.76) 1(0.16) 351(56.82) 90(14.59) 46(7.46) 65(10.53) 617 
Faisalabad 19(5.89) 08(2.49) 0(0) 180(55.72) 29(8.97) 33(10.21) 54(16.72) 323 
Gojra 19(8.71) 05(2.29) 1(0.46) 124(56.89) 50(22.93) 02(0.92) 17(7.80) 218 
Shakarghar 12(10.43) 02(1.74) 01(0.87) 65(56.53) 24(20.86) 4(3.48) 7(6.09) 115 
Dipalpur 06(3.65) 09(5.48) 01(0.62) 77(46.95) 21(12.80) 16(9.76) 34(20.73) 164 
Pir Mahal 05(4.54) 09(8.18) 01(0.90) 62(56.36) 15(13.64) 06(5.45) 12(10.91) 110 
Darya khan 4(5.63) 2(2.82) 0(0) 35(49.30) 17(23.94) 04(5.63) 09(12.68) 71 
Jaranwala 06(8.33) 01(1.39) 0(0) 43(59.72) 08(11.11) 04(5.56) 10(13.89) 72 
p-value 0.000  0.000 IS 0.0000 0.0000 0.000 0.000  
Note: UN = undetermined; percentages (%) in parenthesis; IS = insignificant 
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were infected by more than one HCV genotypes 
in Lahore. 65 (10.53 %) isolates were 
undetermined. From Faisalabad 323 patients 
were genotyped and their distribution was 
observed as 180 (55.72 %) as 3a, 29 (8.97 %) as 
3b, 19 (5.89 %) as 1a, 8 (2.49 %) as 1b and 33 
(10.21 %) with mixed genotype. 218  patients of 
Gojra had depicted genotypic prevalence as 124 
(56.89 %)  were identified  as 3a while 50 (22.93 
%) as 3b, 1a was observed in 19 (8.71 %)  
patients and 1b in only 05 (2.29 %) patients, 17 
(7.80 %)  patients were coinfected. 115 HCV 
infected patients from Shakargarh had shown 
genotypic distribution as 65 (56.33 %) confirmed 
as 3a, 24 (20.86 %) as 3b, 12 (10.43 %) as 1a, 
02 (1.74 %) as 1b and 04 (3.48 %) as mix 
genotype. From Dipalpur 164 patients had shown 
genotypic distribution as; 77 (46.95 %) as 3a, 21 
(12.80 %) as 3b, 06 (3.65 %) as 1a, 09 (5.48 %) 
as 1b and 16 (9.76 %) as mix genotype. 
Prevalence of genotype from 110 HCV infected 
patients of Pir Mahal was observed as: 62 (56.36 
%) as 3a, 15 (13.64 %) as 3b, 05 (4.54 %) as 1a, 
09 (8.18 %) as 1b and 06 (5.45 %) as mix 
genotype. 12 (7.29 %) samples could not be 
genotyped. 71 genotyped patients of Darya Khan 
had shown genotypic distribution as; 35 (49.30 
%) as 3a, 17 (23.94 %) as 3b, 4 (5.63 %) as 1a, 
2 (2.82 %)as 1b and 04 (5.63 %) were infected 
by more than 1 genotype. 
 
From Jaranwala, 72 HCV infected patients had 
shown genotypic picture as: 43 (59.72 %) as 3a, 
08 (11.11 %) as 3b, 06 (8.33 %) as 1a, only one 
patient as 1b and 04 (5.56 %) patients as mix 
genotype. All the studied HCV genotypes (p-
value < 0.05) have statistically significant 
variation except 2a (p > 0.05) for different cities 
of Punjab. The data of HCV genotype distribution 
in different age groups were arranged between 
10+ to 70+ (Table 3). Genotype 3a was most 
prevalent in age group 30+ (n = 381, 70.56 %) 
followed by 20+ (n = 98, 57.99 %) and 50+ (n = 
161, 50.16 %). Overall variation of HCV 
genotypes with different age groups is significant 
(p < 0.05). 
Viral load distribution was divided into three 
categories based on its viral load levels such as 
low (<200,000 IU/ml), intermediate (200,001-
600,000 IU/ml) and high (>600,000 IU/ml). Male 
and female patients were divided into 3 
categories of viral load as 487 (41.77 %) and 206 
(39.31 %) low, 249 (21.36 %) and 115 (21.95 %) 
intermediate, 430 (36.88 %) and 203 (38.74 %) 
high respectively. Patients infected by Genotype 
3 were grouped into three viral load categories 
as low 626 (52.56 %), intermediate 188 (15.79 
%) and high 377 (31.65 %) respectively. Patients 
those were infected by other HCV genotypes 
were grouped into low, intermediate and high 
categories of viral load as 67 (13.43 %), 176 
(35.27 %) and 256 (51.3 %) respectively. Viral 
load categories Genotype3 and Other for both 
genders are insignificant and for different cities of 
Punjab they are statistically significant for all 




HCV is a major threat of the century; this is 
because of the nature of this virus which makes it 
difficult to treat. It leads to develop in severe 
conditions like liver cirrhosis and hepato-cellular 
carcinoma and also responsible in making 
people carrier of HCV. In India about 12–13 
million HCV carriers were reported. With the 
change in the type of genotype, length of 
treatment and dosage of antiviral therapy can be 
changed. Viral response to interferon therapy is 
changed with genotype, such as genotype 3 and 
1 gives better response. So HCV genotypes 
were very critically evaluated. The genotype of 
HCV varies along with geographical areas such 
as genotype 3a following genotype 1 was more 
prevalent in India in 2011 [8]. 
 
In the United States high prevalence of HCV 
subtypes 1a and 1b are well documented.  In 
Europe HCV types 1b and 2, in Thailand,   
 
  
Table 3: Age-wise HCV genotype/subtype distribution in Punjab, Pakistan (n = 1690) 
 
Genotypes/ subtypes 
Age groups                    1a 1b 2a 3a 3b Mixed Undetermined Total 
10+ 0 (0) 0(0) 3(9.09) 13(39.40) 8(24.24 ) 2(6.06) 7(21.21) 33 
20+ 13(7.69) 10(5.9) 0(0) 98(57.99) 13(7.69) 9(5.32) 26(15.38) 169 
30+ 36(6.66) 4(0.74) 1(0.18) 381(70.56 ) 32(5.93) 25(4.63) 61(11.30) 540 
40+ 26(5.09) 13(2.53) 0(0) 238(46.39) 136(26.50) 37(7.21) 63(12.28) 513 
50+ 18(5.60) 21(6.54) 0(0) 161(50.16) 49(15.26) 31(9.66) 41(12.78) 321 
60+ 11(13.92) 5(6.33) 1(1.27) 35(44.30) 11(13.93) 9(11.39) 7(8.86) 79 
70+ 14(40.0) 0(0) 0(0) 11(31.43) 5(14.29) 2(5.71 ) 3(8.57) 35 
Note: % in parenthesis  
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Table 4: HCV viral load categories and their distribution by gender and genotypes in different cities of 
Punjab, Pakistan 
 
HCV viral load    
  IU/ml 200,001- IU/ml IU/ml   
City  
    
<200,000 




Males 487 41.77 249 21.36 430 36.88   
Females 206 39.31 115 21.95 203 38.74 0.630 
Punjab Genotype3 626 52.56 188 15.79 377 31.65  
  Other  67 13.43 176 35.27 256 51.3 <0.001 
Lahore Genotype3 220 49.89 77 17.46 144 32.65  
  Other  19 10.8 37 21.02 120 68.18 <0.001 
Faisalabad Genotype3 69 33.01 36 17.22 104 49.76  
  Other  10 8.77 40 35.08 64 56.14 <0.001 
Gojra Genotype3 126 72.41 8 4.59 40 22.99  
  Other  11 25 26 59 7 15.9 <0.001 
Shakargarh Genotype3 61 68.54 17 19.1 11 12.36  
  Other  6 23.07 7 26.92 13 50 <0.001 
Depalpur Genotype3 58 59.18 10 10.2 30 30.61  
  Other  4 6.06 35 53.03 27 40.91 <0.001 
Peer Mahal Genotype3 49 63.64 19 24.68 9 11.69  
  Other  7 21.21 16 48.48 10 30.3 <0.001 
Darya 
Khan Genotype3 15 28.84 16 30.76 21 40.38  
  Other  5 26.31 7 36.84 7 36.84 0.889 
Jaranwala Genotype3 28 54.9 5 9.8 18 35.3  
  Other  5 23.81 8 38.1 8 38.1 0.002 
 
genotypes 1a, 6a, and 3a, in Hong Kong, 
genotype 6a while in China subtype 1b is 
predominant [9]. When data were analyzed in 
different cities of Punjab Pakistan. It was 
observed that Genotype 3a was most dominating 
among other genotypes with a prevalence rate of 
55.44 % followed by 3b (15.03 %), 1a (10.12 %), 
1b (3.14 %) and 2a (0.3 %). No particular 
difference was noticed in prevalence of genotype 
based on gender classification. Maximum gender 
ratio was for genotype 1a which was 3.54 while 
the minimum was 1.30 which was for genotype 
1b. Female patients were 3.69 % more affected 
than males in infection caused by mixed 
genotypes. Here , regional difference was 
observed in different cities of Punjab, as 
genotype 3a had shown 12.77 % higher 
prevalence in Jaranwala  59.72 % than Dipalpur 
46.95 %, while patients of Darya Khan 23.94 % 
were found to be 14.97 % more infected by 
genotype 3b than Faisalabad 8.97 %. Genotype 
1a was found to be 6.78 % more prevalent in 
Shakargarh (10.43 %) than Dipalpur (3.65 %). 
Genotype 1b was most prevalent in Pir Mahal 
8.18 %. Patients infected by mixed genotype had 
shown highest prevalence in Dipalpur (18.92 %), 
whereas only two patients were coinfected in 
Gojra out of 218 studied patients. Ahmad et al [1] 
reported genotype 3a was 55.9 % in Lahore. 
There is a shift in genotype distribution with 
increasing prevalence in genotypes 3a, 1a and 4 
in Pakistan and some other countries due to 
migration [10]. It was found that HCV male 
patients were more affected than females which, 
also relates to data of a study conducted at the 
Jinnah Postgraduate Medical Centre, Karachi 
[11]. The results were analyzed according to age 
groups of patients in association of different HCV 
genotype. Patients of age group 30+ (70.56 %) 
had shown the highest infection rate of HCV 
genotype 3a. Genotype 3b had shown highest 
infection rate in age group 40+ (26.50 %) and 
had least infected to patients of age group 30+ 
(5.93 %). Genotype 1a had infected 40 % 
patients of age group 70+ and had not infected 
any person of age group 10+. Genotype 1b had 
victimized 6.54 % patients of age group 50+ and 
age groups 10+, and 70+ were safe from this 
virus. Prevalence of coinfection was highest in 
age group 60+. It was reported that people < 40 
years of age were more affected with HCV 
[11;12]. In contrast Muhammad et al, [13] 
reported that the high HCV prevalence rate in 
Pakistan was found in old age group people. 
Here it was observed that genotype 1 is more 
prevalent in old age (70+) patient group while 3a 
in 30+ and 3b in 40+ age group. It is therefore 
suggested that evolution of different genotypes 
according to age group of patients should be 
studied further with large sample size. Although 
the significant relation was found in genotype 
distribution of HCV, age and gender, which is 
also documented in several studies [12]. The 
other significant feature is viral load titers which 
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is a great prognostic indicator that helps in 
treatment decisions. Actually patients with high 
viral load present a poor response to interferon 
therapy than those with low viral titers. No 
particular difference in viral loads was observed 
among both genders as low titers had been 
shown by 41.77 % males and 39.31 % 
females,while intermediate titers were analyzed 
in almost 21 % patients of both genders and high 
viral load titers were shown by 36.88 % males 
and 38.74 % females. But significant difference 
in viral loads was observed in patients infected 
by genotype 3 and others. Patients infected by 
genotype 3 and others. Patients infected by 
genotype 3 had shown 39.13 % more viral load 
titers in low category than patients infected by 
other genotypes. On the other hand patients 
infected by other genotypes had shown 19.65 % 
more viral loads titers in high category than 
patients infected by genotype 3. When data were 
analyzed in term of viral load in different cities of 
Punjab it was observed that maximum 
percentages of patients victimized by genotype 3 
were exhibiting low HCV RNA titers were in 
Shakargarh 68.54 %. Association of HCV 
genotypes and viral load remains point of 
discussion [8]. Some studies showed a close 
association of high viral load with advanced liver 
stage and some showed no relation with 
viraemia [14]. 
 
Here the core gene fragment of HCV genome 
was reversed transcribed and amplified 
successfully from the serum of patients from 
Punjab province of Pakistan.  The fragment was 
sequenced and highly expressed in E.coli. 
(Figure 5) The results of ELISA showed greater 
antigenicity of the recombinant protein, which 
demonstrated good prospects of using protein as 
an antigen to detect HCV antibodies. The 
nucleotide sequence homology analysis 
indicates the HCV isolates in this study 
(FR851292) belong to HCV core gene like Japan 
(D14309) and USA (EU099417).  Previously this 
type of HCV was already isolated from this 
region [15]. This gives the idea that for endemic 
HCV this ELISA based kit method is much better 
because of local recombinant protein [16].  
 
Figure 5: SDS PAGE analysis of un induced (lane 1) 
and induced in E. coli cells carrying HCV core gene. 
Lane 1: E.coli containing pET21a (+), un 
induced. 
Lane 2-3: E. coli containing pET21a(+), induced. 
CONCLUSION 
 
The study indicates that genotype 3 is the 
predominant genotype in Punjab, Pakistan 
followed by genotype1. Baseline viral load is 
significantly high in patients with other genotypes 
(1a, 1b, 2a, 3b, mixed genotypes and 
undetermined genotypes) compared to genotype 
3. Regional differences also exist for genotypes. 
Moreover, we have successfully expressed 
recombinant HCV core antigen. This antigen 
used to develop local screening assay may be 




This study was supported by Higher Education 




1. Ahmad W, Ijaz B, Javed TF, Jahan S, Shahid I, Khan FM, 
Hassan S. HCV genotype distribution and possible 
transmission risks in Lahore, Pakistan. W. J. 
Gastrol. 2010; 16: 4321-4328. 
2. George M, Lauer MD, Bruce D, Walker MD. Hepatitis C 
virus infection. 2001; N. Engl. J. Med. 1: 41-52. 
3. Husain A, Malik FA, Nagra H, Ehsan A, Ahmad Z, Abid M. 
Frequency of Different HCV Genotypes in 
Faisalabad. Anal. Punj. Med. Col. 2009; 3:19-22. 
4. Fukutomi T, Zhou Y, Kawai S, Eguchi H, Wands JR, Li J. 
Hepatitis C virus core protein stimulates hepatocyte 
growth: correlation with up regulation of wnt-1 
expression. Hepatology. 2005; 41: 1096-1105. 
5. Raja NS, Janjua KA. Epidemiology of hepatitis C virus 
infection in Pakistan. J. Microbiol. Immunol. Infect. 
2008; 41: 4–8. 
6.  Library of Congress, Federal Research Division. 2005 
[cited 2008 Aug 18]. Available 
from:http://lcweb2.loc.gov 
7.  The NuGO Bioethics Guidelines on Human Studies, 2007 
[cited 2008 Apr 20]. Available from 
http://nugo.dife.de/bot/index. 
8. Chakravarti A, Dogra G,  Verma V,  Srivastava P. 
Distribution pattern of HCV genotypes and its 
association with viral load, Ind. J. Med. Res. 2011; 
133: 326–331. 
9. Liu JY, Lin H, Liu Y, Lee S, Chen Y, Hung C, Ko W, Huang 
C, Lai C, Chen Y, Shih Y, Chung H, Liang S, Lin N. 
Extremely High Prevalence and Genetic Diversity 
of Hepatitis C Virus Infection among HIV-Infected 
Injection Drug Users in Taiwan. Clin. Infect. Dis. 
2008; 46: 1761–1768. 
10. Ijaz T, Khan MA, Jafri SA, Ranjha FA, Mehmood KA, 
Imran M, Shahzad MK. Prevalence of Hepatitis C 
Virus (HCV) Genotype 3a in the Infected 
Population of Lahore, Pakistan. Int. J. Infect. Dis. 
2008;1: S421-S425 
11. Ahmed W, Arif A, Alam SE, Qureshi H.  Changing trend 
of viral hepatitis - “A twenty one year report from 
Pakistan Medical Research Council Research 
Centre, Jinnah Postgraduate Medical Centre, 
Karachi. J. Pak. Med. Assoc. 2010; 60; 86-9. 
12. Shah FU, Salih M, Malik IA, Hussain I. Increasing 
prevalence of chronic hepatitis and associated risk 
factors. Pak. J. Med. Res.2002; 41:46-50. 
13. Muhammad N, Jan MA. Frequency of hepatitis “C” in 
Buner, NWFP. J. Coll. Physicians. Surg. Pak.2005; 
15: 11-14. 
340 
Bashir et al 
Trop J Pharm Res, June 2013;12 (3): 
 
7 
14. Gretch D, Corey L, Wilson J, Rosa C, Willson R, 
Carithers R. Assessment of hepatitis C virus RNA 
levels by quantitative competitive RNA polymerase 
chain reaction: high titer viraemia correlates with 
advanced stage of disease. J. Infect. Dis.1994; 
169: 1219–25. 
15. Khaliq S, Jahan S, Ijaz B, Ahmad W, Asad S, Pervais A. 
Inhibition of Core gene of HCV 3a genotype using 
synthetic and vector derived siRNAs. Virol. J. 2010; 
7: 318-326. 
16. Waheed Y, Tahir S, Ahmad T, Qadri I. Sequence 
comparison and phylogenetic analysis of core gene 
of hepatitis C virus from Pakistani population. Afr J. 
Biotechnol. 2010; 9: 4561-4567. 
 
 
 
 
341 
